Cantor Fitzgerald & Co.
499 Park Avenue
New York, NY 10022
March 5, 2021
Securities and Exchange Commission
100 F. Street, N.E.
Washington, D.C. 20549
Re: Portage Biotech Inc. (the "Company")
Registration Statement on Form F-3
File No. 333-253468
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby join the Company's request for acceleration of the above-referenced Registration Statement, requesting effectiveness be accelerated to 4:30 p.m. Eastern time on Monday, March 8, 2021, or as soon thereafter as practicable.
| Very truly yours, | |
| CANTOR FITZGERALD & CO. | |
| By: /s/ Sameer Vasudev | |
| Name: Sameer Vasudev | |
| Title: Managing Director |
